[
  {
    "ts": null,
    "headline": "Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=61288c13a6c060b62523979b06bae79d796e246cd7ebed1fd91f06660a3bb956",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768488005,
      "headline": "Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock",
      "id": 138122992,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=61288c13a6c060b62523979b06bae79d796e246cd7ebed1fd91f06660a3bb956"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results",
    "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its fourth quarter earnings conference call will be webcast on Tuesday, February 10, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.",
    "url": "https://finnhub.io/api/news?id=fba886ec2369347d138e1d1bb87c499825fd1edf4d435682ef76757dcb8a7bbc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768480200,
      "headline": "Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results",
      "id": 138120865,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its fourth quarter earnings conference call will be webcast on Tuesday, February 10, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.",
      "url": "https://finnhub.io/api/news?id=fba886ec2369347d138e1d1bb87c499825fd1edf4d435682ef76757dcb8a7bbc"
    }
  },
  {
    "ts": null,
    "headline": "JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US",
    "summary": "According to GlobalData analysis, the surgical robotic market was valued at $10.0bn in 2025 and is projected to reach sales of $17.3bn by 2033.",
    "url": "https://finnhub.io/api/news?id=afc601fe19633a00a050a4480fccb3696125a22a5aaedbe8ea808fd37f932339",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768479028,
      "headline": "JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US",
      "id": 138120769,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "According to GlobalData analysis, the surgical robotic market was valued at $10.0bn in 2025 and is projected to reach sales of $17.3bn by 2033.",
      "url": "https://finnhub.io/api/news?id=afc601fe19633a00a050a4480fccb3696125a22a5aaedbe8ea808fd37f932339"
    }
  },
  {
    "ts": null,
    "headline": "Is Executive Exit And Cautious Guidance Altering The Investment Case For Zimmer Biomet (ZBH)?",
    "summary": "Zimmer Biomet Holdings, Inc. recently disclosed that former executive officer Mark Bezjak will resign from the company on January 16, 2026, while management has also struck a cautious tone on future performance and guidance at the J.P. Morgan Healthcare Conference. These developments come as CEO Ivan Tornos prepares a major direct-to-consumer campaign and emphasizes realistic expectations around the company’s transformation plans through 2026. We’ll now examine how management’s more cautious...",
    "url": "https://finnhub.io/api/news?id=105f38d003c338ab6b37db8720c76f98a9a34250ea68d5bfd1819c888e575055",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768460844,
      "headline": "Is Executive Exit And Cautious Guidance Altering The Investment Case For Zimmer Biomet (ZBH)?",
      "id": 138118346,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet Holdings, Inc. recently disclosed that former executive officer Mark Bezjak will resign from the company on January 16, 2026, while management has also struck a cautious tone on future performance and guidance at the J.P. Morgan Healthcare Conference. These developments come as CEO Ivan Tornos prepares a major direct-to-consumer campaign and emphasizes realistic expectations around the company’s transformation plans through 2026. We’ll now examine how management’s more cautious...",
      "url": "https://finnhub.io/api/news?id=105f38d003c338ab6b37db8720c76f98a9a34250ea68d5bfd1819c888e575055"
    }
  }
]